Ovarian Endometrioid Adenocarcinoma — Trials

Ovarian Endometrioid Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

73 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 13
Ph III recruiting: 4
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04611139	Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers	withdrawn	Phase 1	0	HonorHealth Research InstituteOTHER	1	Mar 2, 2022	clinicaltrials

Data updated 23 days agoSource updated Mar 2, 2022source: clinicaltrials